HBV genes induce cytotoxic T‐lymphocyte response upon adeno‐associated virus (AAV) vector delivery into dendritic cells
Hong You(Harbin Institute of Technology), Paul L. Hermonat(University of Arkansas for Medical Sciences), Changxuan You(Southern Medical University), Minghua Cong(Chinese Academy of Medical Sciences & Peking Union Medical College), J. L. Mehta(University of Arkansas for Medical Sciences), Y. Liu(University of Arkansas for Medical Sciences), David Jitao Zhang(University of Arkansas for Medical Sciences)
Cited by 14
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
|Annals of Oncology|2015|467
A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer
|Frontiers in Endocrinology|2022|161
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156
Oxidized LDL, a critical factor in atherogenesis☆
|Cardiovascular Research|2005|142